Aim: To evaluate the predictive value of circulating endothelial-derived apoptotic microparticles (EMPs) to proangiogenic mononuclear cells (MPCs) ratio for cumulative survival in patients with ischemic chronic heart failure (CHF). Methods: A total of 154 patients with moderate-to-severe CHF were enrolled in the study. Flow cytometry analysis for quantifying the number of EMPs and proangiogenic MPCs was used. Results: Calculated EMPs to MPCs ratios in survived and died patient cohort were 0.84 (95% CI = 0.76 -0.92) and 7.89 (95% CI = 5.30 -11.66) respectively
Introduction
Endothelial dysfunction plays a critical role in the clinical manifestations of CHF [10, 11] . Recent studies suggested that injure of endothelial monolayer due to any reasons leads to dramatic increase of circulating level of endothelial-derived apoptotic microparticles (EMPs) [19] . EMPs are a heterogeneous population of submicronic vesicles that are released in response to cell activation or apoptosis [7] . It has been investigated that EMPs represent an intercellular communication and delivery mechanism for the efficient and effective transfer of biological information [15] . Increase in circulating EMPs is detectable in several cardiovascular diseases, such as acute coronary syndrome, atherosclerosis, dyslipidaemia, hypertension, stroke, atrial fibrillation, as well as sepsis, cancer, lupus erythematosus, chronic kidney disease, type two diabetes mellitus, obesity [9] . Circulating mononuclear progenitor cells (MPCs) ensure reparative processes including endotelization of fragments of vascular lesion, as well as remodelling of extracellular matrix and neoangiogenesis [7] . Mobilization of bone-marrow MPCs is regulated by a wide range of pro-inflammatory cytokines and signal molecules [6] . At the same time, mature endothelial cells also can differentiate from activated mononuclears mobilized from peripheral tissues [5] . As well as EMPs, circulating proangiogenic MPCs are involved in the process of vasculogenesis repairing damaged and dysfunctional endothelium [1] . Because no association between CD34+CD45-phenotyped circulating MPCs and survival of the CHF patients was found, other subpopulations of MPCs coexpressing CD34+ antigen and VEGFR-2+ vascular growth ligands (Vascular Endothelial Growth Factor Rreceptor-2), CD133+, CD14+, and Tie2+ were tested as predictors of nature evolution of ischemic CHF [2, 19] . The aim of this study was to evaluate the potential prognostic value of circulating EMPs to MPCs ratio for cumulative Circulating apoptotic microparticles to mononuclear cells ratio 13 survival in patients with ischemic CHF.
Methods
The study evolved 154 patients (86 males) aged 48 to 62 years with ischemic symptomatic moderate-to-severe CHF. Table 1 shows characteristic of the patients participated in the study. All the patients have given their written informed consent for participation in the study. Observation period was up to 3 years. We analyzed cumulative survival related to CHF, and additionally all-cause mortality was examined. Multispiral computed tomography angiography and/or angiographic study have been carried out to verify the ischemic nature of the disease in patients. Multispiral computed tomography angiography has been carried out for all the patients prior to their inclusion in the study. When atherosclerotic lesions of the coronary arteries were verified, patients were subjected to conventional angiographic examination provided indications for revascularization were available. CAD was considered to be diagnosed upon availability of previous angiographic examinations carried out not later than 6 months ago provided no new cardiovascular events occurred for this period, and the procedure are available for assay. Transthoracic ultrasonic echocardiography was performed according to a conventional procedure on ACUSON apparatus, SIEMENS, Germany, in В-mode regimen and tissue Doppler echocardiography regimen from parasternal, subcostal, and apical positions over the short and long axis with sensor Р of 5 МHz. Left ventricular end-diastolic and end-systolic volumes were measured by modified Simpson's planimetric method; and they were measured by cylinder method if severe failure of local myocardial contractility was verified. Left ventricular ejection fraction (LVEF) was assessed in compliance with the requirements of American Society of Echocardiography [18] . Tissue Doppler echocardiography was carried out in 4-, 3-and 2-chamber projections in each of 16 segments of the left ventricle and in 4 spots of the mitral annulus: at the base of posterior septal, lateral, inferior, and anterior left ventricular walls [16] . Peak systolic (Sm), early diastolic (Em), and late diastolic (Аm) myocardial velocities were measured in the mitral annulus area, followed by calculating velocity of early diastolic left ventricular filling (E) to Аm (Е/Аm) ratio and to Em (Е/Em) ratio. Calculation of glomerular filtration rate (GFR) was carried out using MDRD-6 formula [11] . To determine N-terminal pro-brain natriuretic peptide (NT-pro-BNP), total cholesterol and cholesterol fractions, blood samples were drawn in the morning (at 7-8 a.m.) into cooled silicone test tubes. Samples were processed according to the recommendations of the manufacturer of the analytical technique used. They were centrifuged upon permanent cooling at 6,000 rpm for 3 minutes. Then, plasma was refrigerated immediately to be stored at a temperature not higher than о С. Circulating NT-pro-BNP level was measured by immunoelectrochemoluminescent assay using sets by R&D Systems (USA) on Elecsys 1010 analyzer (Roche, Mannheim, Germany). Concentrations of total cholesterol (TC) and cholesterol of high-density lipoproteins (HDLP) were measured by fermentation method. Concentration of cholesterol of low-density lipoproteins (LDL-C) was calculated according to the Friedewald formula (1972). Endothelial-derived apoptotic microparticles were phenotyped by flow cytofluorimetry by phycoerythrin (PE)-conjugated monoclonal antibody against CD31 (BD Biosciences, USA) followed by incubation with fluorescein isothiocyanate ( 
Statistical Analysis
Statistical analysis of the results obtained was carried out in SPSS system for Windows, Version 22 (SPSS Inc, Chicago, IL, USA). The data were presented as mean (М) and error of mean (±m) or 95% confidence interval (CI); median (Ме) and interquartile range. To compare the main parameters of patients' groups, onetailed Student t-test or Shapiro-Wilk U-test were used. To compare categorical variables between groups, Chi 2 test (χ2) and Fisher F exact test were used. The factors, which could be associated potentially with EMPs to MPCs ratio, were determined by logistic regression analysis. Odds ratio (OR) and 95% confidence interval (95% CI) were calculated for all the independent predictors of survival of the patients. A calculated difference of P<0.05 was considered significant.
Results
During a median follow-up of 2.18 years, 21 participants died and CHF-related death was defined in 18 patients. Additionally, 106 subjects were hospitalized repetitively due to advance CHF (17 cases in died cohort and 89 cases in survival cohort). Table 1 shows a general characteristic of the patients included in the study. As one can see from Table 1 , no substantial age and gender differences were found among persons who died and survived, as well as differences in body mass index (BMI), glomerular filtration rate (GFR), HbA1c, fasting blood glucose level, blood creatinine level, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), numerous of coronary vessels damaged. No difference was found between the two cohorts in systemic office blood pressure (BP) and heart rate (HR). Documented incidence of type 2 diabetes mellitus in patients of the two cohorts was 38.1% and 33.8% (P=0.06). Note that there was not a statistically significant change in Е/Аm and Е/Em between the two cohorts, while decrease in the left ventricular ejection fraction value was quite anticipated in the setting in died patients. At the same time, the level of circulating NT-pro-BNP was statistically significantly higher in died patients than in survived persons. When analyzing details of pharmacotherapy, no substantial differences were found between the two cohorts with regard to administration of the majority of drugs.
Circulating EMPs and MPCs level in survival and died patients
Medians of circulating levels of EMPs in survived and died patient cohort were 0.286 n/mL (95% confidence interval [CI] = 0.271-0.309 n/mL) and 0.673 n/mL (95% CI = 0.65-0.74 n/mL) (P<0.001). Medians of circulating levels of MPCs in both patient cohorts were 0.28 n/µL (95% CI = 0.26 -0.30 n/µL) for survived persons and 0.12 n/µL (95% CI = 0.098 -0.14 n/µL) for subjects who died (P=0.001). Calculated EMPs to MPCs ratios in survived and died patient cohort were 0.84 (95% CI = 0.76 -0.92) and 7.89 (95% CI = 5.30 -11.66) respectively (P=0.001). EMPs to MPCs ratio was directly related to NYHA functional class of CHF (r = 0.62, P = 0.001), NT-pro-BNP (r = 0.513, P = 0.001), T2DM (r = 0.422, P = 0.001), multi-vessel lesion of coronary arteries (r = 0.432, P = 0.001), Е/Аm (r = 0.387, P = 0.002), Е/Em (r = 0.356, P = 0.002), gender (r = 0.396, P < 0.001 for male), TC (r = 0.322, P = 0.001), age (r = 0.301, P = 0.001), smoking (r = 0.287, P = 0.001) and inversely to LVEF (r = -0.506, P = 0.001) and estimated GFR value (r = -0.502, P = 0.001). No significant association between the EMPs to MPCs ratio with fasting plasma glucose, HbA1c, means systolic and diastolic BP, premature CAD in family anamnesis, and medications for both cohorts of the patients was found. For further analysis the values of EMPs to MPCs ratio for entire patient population included in the study obtained by calculation were distributed by quartiles (Q): Q1 (median = 0.97; 95% CI = 0.58 -1.06); Q2 (median = 1.82; 95% CI =1.10 -2.22); Q3 (median = 4.14; 95% CI =2.25 -5.78); Q4 (median = 7.30; 95% CI =5.89 -9.66). Using Kaplan-Meier survival analysis we have been found a significantly divergence of survival curves in patients with top quartile (Q4) of EMPs to MPCs ratio when compared with low quartiles (Q1-Q3) (Figure 1 ). The curves divergence of events accumulation reached a statistical significance in 50 weeks of observation period (P<0.001 for all cases). No statistically significance differences between survival in patient cohorts with Q1 and Q2, as well as Q2 and Q3 EMPs to MPCs ratio were found. The divergence between two cohorts with EMPs to MPCs ratio equal Q1 and Q3 was reached be able significance at study end. Multivariate logistic regression was used to assess whether any combination of assays was able to better discriminate between survival and died patients. In the logistic regression analysis, the main factors independently related with cumulative mortality and CHF-related re-hospitalisations were EPMs, MPCs, EPMs to MPCs ratio, NT-pro-BNP, NYHA class, LVEF, T2DM, and three-and multi-vessel lesion. Noteworthy, EPMs to MPCs ratio had the most independently predicted potential for all-cause mortality (OR = 1.69; 95% CI = 1.40-1.92; P = 0.001), CHF-related death (OR = 1.38; 95% CI 1.20-1.54; P = 0.001), and also CHF-related rehospitalisation (OR = 1.32; 95% CI = 1.18 -1.66; P=0.001) when compared with other variables (Table 2) . MPCs, EMPs, NYHA class, NT-pro-BNP and LVEF remained statistically significant for all categories: all-cause mortality, CHF-related death, and CHF-related re-hospitalisations, whereas T2DM and three-and multi-vessel lesion for all variables did not. Using a stepwise model selection method for multivariable prediction model we have been investigated the summary effect of any combinations of EPMs to MPCs ratio, NT-pro-BNP, LVEF on all-cause mortality, CHF-related death, and CHFrelated re-hospitalisations (Table 3) . We found that EPMs to MPCs ratio remained statistically significant predictors for combined end-point included all-cause mortality and CHF-related re-hospitalisations. A stepwise model selection method has been demonstrated that NT-pro-BNP, NYHA class, LVEF, T2DM and threeand multi-vessel lesion of coronary arteries added to EPMs to MPCs ratio do not offer any additional information to discriminate between survived and died patients with symptomatic ischemic CHF.
Discussion
Because endothelium is one of the primary targets of circulating EMPs, hens EMPs have been considered as biomarkers of vascular injury, inflammation and stage of progression of cardiovascular diseases. Recent study has been revealed an association between circulating EMPs labelled as CD31 + / annexin V + cells and MPCs with different nature with cardiovascular outcomes [13] . However, no previous study has mentioned the possible predicted role of circulating EMPs levels and MPCs count in the CHF. In our investigation we found a significantly increase of EMPs to MPCs ratio in circulation in ischemic CHF patients who were died when compared with those who survived. Quartile distribution of EMPs to MPCs ratio with further cumulative survival analysis with Kaplan-Meier has been shown a significant divergence between curves in Q4 EMPs and other quartiles. Using stepwise predictive methods we found that increased EMPs to MPCs ratio independently predicted combined end-point (all-cause mortality and CHF-related rehospitalisation) within observation period. Multivariable prediction model has been shown a high decremented potential of EMPs to MPCs ratio alone, when compared with other markers of unfavourable of clinical outcomes suitable for CHF, such as NT-pro-BNP and LVEF. These findings suggest that increased EMPs to MPCs ratio might improve the predictive value of contemporary model in CHF based on clinical performances and NT-pro-BNP measurements. Although the cellular mechanism of action of EMPs largely remains unclear, we believe that increased EMPs to MPCs ratio in CHF may reflect a reduced vascular repair capacity and severity of endothelial dysfunction, that is, probably, considered as staging disease. In this study, EMPs to MPCs ratio was sufficient to predict long-term changes significant as independent factors in cumulative survival, re-hospitalisation due to CHF, and CHF-related death. It should emphases that while EMPs and MPCs have large diagnostic potential as biomarkers in cardiovascular diseases and cancer; however, due to current technological limitations in purification of EMPs and an absence of standardized methods of detection, the role of EMPs became controversial [3] . Probably, some obstacles related with FACS methodology, might be an explanation why not for cases a tremendous relation between circulating EMPs and MPCs were found [20] . Probably, risk factors contribute CHF evolution through suppression of mobbing, differentiation and migration of proangiogenic progenitor cells, as well as increase of endotheliocytes apoptosis. Hens, calculation of EMPs to MPCs ratio looks attractive for interpretation data of EMPs and MPCs measurements that reflects tenderness of existing imbalance between apoptosis of endotheliocytes and repair of endothelium. However, no more studies dedicated investigation of prognostic role of such ratio in cardiovascular disease patients, although dissociation between circulating apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria has also described. New studies with more statistical powerful are required.
Conclusion
Among patients with symptoms of CHF, top quartile of EMPs to MPCs ratio associates with increased 3-year CHF-related death, all-cause mortality, and risk for recurrent hospitalization due to CHF.
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